CEO Richard Twomey leaves Mölnlycke
Richard Twomey, President and CEO of Mölnlycke, will after six years leave the organisation."Richard has with his deep knowledge and experience within the medical technology industry developed Mölnlycke into an even stronger company in its field. During his time the company has made significant progress, especially in emerging markets. It has also made big strides in innovation and the establishment of solid clinical evidence and health economics related to our products. Going forward, the strategy remains the same as we are now speeding up the execution phase", says Chairman Gunnar Brock.